Autolus Therapeutics (AUTL)

Autolus Therapeutics (AUTL) stock research: performance, analysts' price targets, earnings, revenue and margins, technicals and insider trades.

• AUTL last traded at $1.52, -3.80% on the day.
• Autolus Therapeutics: market cap $404.57M, P/E -1.3, revenue $117.35M over the last four quarters, next earnings 2026-11-10.
• Over the past year AUTL returned 0.66%; year to date -23.62%.

Updated 2026-11-02 19:07 UTC